WebAug 2, 2024 · NEWARK, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic... WebMar 22, 2024 · The Fly CymaBay price target raised to $12 from $10 at H.C. Wainwright. 5d ago. CBAY. The Fly CymaBay reports Q4 EPS (30c), consensus (30c) 6d ago. CBAY. Press Releases CymaBay Reports Fourth Quarter and Year Ended December 31, 2024 Financial Results and Provides Corporate Update. 6d ago.
This report offers a comprehensive analysis of the competitive ...
WebLatest News CymaBay Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 16, 2024 Mar 9, 2024, 4:05 PM EST CymaBay … WebApr 11, 2024 · The Cymabay Therapeutics Inc stock price gained 2.46% on the last trading day (Thursday, 6th Apr 2024), rising from $8.55 to $8.76. During the last trading day the stock fluctuated 3.24% from a day low at $8.50 to a day high of $8.77. The price has fallen in 6 of the last 10 days and is down by -2.12% for this period. bitload4u
CBAY - CymaBay Therapeutics Inc Stock quote - CNNMoney.com
WebGet the latest CymaBay Therapeutics Inc (CBAY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebMay 21, 2024 · $848M Today's Change (-2.90%) -$0.26 Current Price $8.72 Price as of March 31, 2024, 4:00 p.m. ET A do-over on one of its drugs is a potential game-changer for CymaBay. Shares of CymaBay... WebView the latest CymaBay Therapeutics Inc. (CBAY) stock price, news, historical charts, analyst ratings and financial information from WSJ. CBAY CymaBay Therapeutics Inc. … data breach in healthcare articles